Cochlear

Cochlear Short-term Debt

The Short-Term Debt of Cochlear (COH.AX) as of Oct 8, 2026 is 42.00 M AUD. In the previous year, Short-Term Debt was 42.20 M AUD — a change of -0.47% (lower).

Short-term Debt

42.00 MAUD

YoY

-0.47%

Last updated:

Short-Term Debt of Cochlear is 2026 42.00 M AUD. Short-Term Debt of Cochlear was 2025 42.20 M AUD. It decreases by -0.47% lower compared to the previous year.

The Cochlear Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2019
3.30 M AUD
Jan 1, 2020
419.10 M AUD
Jan 1, 2021
31.90 M AUD
Jan 1, 2022
78.70 M AUD
Jan 1, 2023
39.20 M AUD
Jan 1, 2024
41.60 M AUD
Jan 1, 2025
42.20 M AUD
Jan 1, 2026
42.00 M AUD
The Cochlear Short-term Debt history
YEARShort-term DebtYoY
42.00 MAUD-0.47%
42.20 MAUD+1.44%
41.60 MAUD+6.12%
39.20 MAUD-50.19%
78.70 MAUD+146.71%
31.90 MAUD-92.39%
419.10 MAUD+12,600.00%
3.30 MAUD-10.81%
3.70 MAUD-95.63%
84.67 MAUD+2,028.51%
3.98 MAUD-97.63%
168.16 MAUD+5,253.68%
3.14 MAUD—
Access this data via the Eulerpool API
Get Free API Key

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Short-Term Debt of Cochlear is 42.00 M AUD in 2026.

Short-Term Debt of Cochlear changed from 42.20 M AUD to 42.00 M AUD, representing a -0.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Cochlear since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Cochlear historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Cochlear

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Cochlear